310 likes | 331 Views
Second Meeting of the (EBC) European Bifurcation Club Friday 29 – Saturday 30 September 2006. Roma , Italia. Tryton Side-Branch Stent. Dr. Aaron V. Kaplan Associate Prof of Medicine Dartmouth Medical School Cardiac Cath Lab Dartmouth-Hitchcock Medical Center.
E N D
Second Meeting of the (EBC) European Bifurcation ClubFriday 29 – Saturday 30 September 2006 Roma, Italia
Tryton Side-Branch Stent Dr. Aaron V. Kaplan Associate Prof of Medicine Dartmouth Medical School Cardiac Cath Lab Dartmouth-Hitchcock Medical Center
AV Kaplan MD: Disclosures • Tryton Medical • Founder • Board of Directors
Clinical Need • High Performance • Tracking = state-of-the-art stent • Guide Compatibility: 5 Fr. • Single Wire Tracking • Definitive Sidebranch Treatment • Coverage = state-of-the-art stent • Hoop Strength = state-of-the-art stent • Address all angulations
Tryton Design Philosophy • Axial Orientation ONLY • Rotational Orientation • Liberal Landing Zone • Tracking Performance = State-of-art Stent • Single Wire Tracking • 5 Fr guide compatible
Provisional Approach Driven by current Stent availability High Cross Over Rate Crossing over to poor options Dedicated Approach Driven by current stent availability Crush ‘T’ Stent Double Barrel Culotte Side-Branch Specific Stent Allows for definitive treatment Dedicated vs Provisional
Tryton Side-Branch Stent Side Branch Side Branch Region Standard Design Transition Zone Coverage Hoop Strength Main Vessel Main Vessel Region 3 Fronds - Minimal Coverage Wedding Band Cobalt Chromium Strut Thickness: 0.003” Diameter: 2.5 mm
Stent Delivery Systems Single Wire Tracking Rotational Independence Liberal (4 mm) Landing Zone Stent Border Markers (19 mm) Transition Zone Markers (4 mm) Stent Delivery System • Rapid Exchange • Low Profile • 5Fr. Guide compatible • Tracking = Zeta • Balloon • Semi-compliant • Rated Burst = 16 ATM • Stent Length = 18 mm Standard Balloon Step Balloon
1. Position Side-Branch Stent Transition Zone Markers
Demonstration of Complete Coverage (OCT) Acute Porcine Model . S. Carlier, M.D. J. Moses, M.D. (Columbia/CRF)
Acute Porcine Studies: Gross Exam Tryton Side-Branch Stent Main Vessel Stent Main Vessel Stent Proximal Region Transition Region Distal Region Dartmouth
Tryton I (First-In-Man Study): Executive Committee Study Sites DSMB Design • N = 30 • Primary Endpoint • Procedural Success • In house MACE • Secondary Endpoints • Procedural:IVUS • 30 Day End Point • 6 month: Angio & IVUS • 9 month:Clinical • M-C Morice (Paris) • E Grube (Siegburg) • M Leon (Columbia/CRF) • AV Kaplan (Dartmouth) • HR Davis (Tryton) • D Kereiakes • AL Bartorelli • M-C Morice (Paris) • E Grube (Siegburg) • P Serruys (Rotterdam)
N = 30 Primary Endpoint Procedural Success In house MACE Secondary Endpoints Procedural: IVUS 30 Day End Point 6 month: Angio & IVUS 9 month: Clinical Design Tryton I (First-In-Man Study): Trial Design
Case 1: Baseline Angiography 84 yo Male with Poor LV Function Left Circumflex-Obtuse Marginal Bifurcation Lesion Medina Classification: 1,1,1
Case 1: Pre-Dilate Main Vessel • Standard Balloon
Case 1: Deploy Main Vessel Stent Side Branch Main Vessel Cypher (3.5x18)
Case 1: Final Simultaneous Kiss • Side Branch Balloon • Main Vessel Balloon
Case 1: Pre-Post Comparison 84 yo Male with Poor LV Function Base Line Final Left Circumflex-Obtuse Marginal Bifurcation Lesion Medina Classification: 1,1,1
Tryton Side-Branch Stent • Performance = Workhorse-Stent • Cobalt Chromium • 5 Fr. Guide Compatible • Single Wire Tracking • Pre-Clinical Evaluation • Coverage • Hoop Strength • FIM-Ongoing • FIM Ongoing • >10 Cases • Initial Results Promising • Completion 4Q 06
The End Thank You aaron.v.kaplan@hitchcock.org